This study stated that DARS-AS1 overexpression heightened EMT in HCC cells, which was specifically reflected in the up-regulation of the mesenchymal markers, N-cadherin and Vimentin, and the down-regulation of the epithelial marker, E-cadherin. This evidence concerns the gene CDH2 and hepatocellular carcinoma.